Does HCV antiviral therapy decrease the risk of hepatocellular carcinoma?
โ Scribed by Maria Pleguezuelo; Laura Marelli; Sergio Maimone; Pinelopi Manousou; Elias Xirouchakis; Andrew K. Burroughs
- Publisher
- Current Science Inc.
- Year
- 2008
- Tongue
- English
- Weight
- 306 KB
- Volume
- 7
- Category
- Article
- ISSN
- 1540-3416
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Objective: To estimate the cost-effectiveness of interferon-a2B for the treatment of patients with chronic hepatitis B infection who are positive for hepatitis B e antigen (HBeAg). Design: Meta-analysis of nine randomized controlled trials and cost-effectiveness analysis, projecting the clinical an
We performed a case-control study to evaluate the risk of hepatocellular carcinoma (HCC) for hepatitis C virus (HCV) infection. A total of 305 newly diagnosed HCC cases (80% males) and 610 subjects (81% males) unaffected by clinically evident hepatic disease admitted to the 2 main hospitals in Bresc